The current trial will enroll 660 patients with damaged discs and chronic low back pain. Patients will receive an injection of either of two stem cell formulations or a placebo to test whether the ...

“Back then there were no ground rules laid out by the MFDS for stem cell therapy, so CORESTEM has been paving the way in this regard, and the path we took was adopted by the MFDS as regulatory ...

He was one of two patients given pioneering stem cell therapy at Moorfields Eye Hospital in London. Cells from a human embryo were grown into a patch that was delicately inserted into the back of ...